Jason Oliviero, MD
Orthopaedic Surgery · Manchester, NHNPI 1023223708
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (39.9%), education and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Kairos Surgical Inc at 57.3% of the total. Reporting peaked in 2019 at $1,899 and has fallen 97.6% since, to $45 in 2025.
Across 19 payments — averaging $269.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$3K
- Encore Medical, LP$1K
- Arthrex$442
- Stryker$159
- Johnson & Johnson$136
- Vericel Corporation$92
- plus $24 from 1 others
What the payments were for
- Speaking & faculty fees$73014%
- Travel & lodging$2,04540%
- Food & beverage$68413%
- Education$1,66032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 6 | $2,934 |
| Encore Medical, LP | 5 | $1,332 |
| Arthrex | 2 | $442 |
| Stryker | 1 | $159 |
| Johnson & Johnson | 2 | $136 |
| Vericel Corporation | 2 | $92 |
| Solventum Corporation | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,120 in reported general payments places this provider in the 65th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 20 | $88 |
| Ondansetron Hcl | 15 | $65 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Manchester
- Douglas GoumasManchester$6K
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- John-Erik BellLebanon$528K
- Michael MorwoodPortsmouth$506K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
- David RichardsNashua$122K
- Philip WolinskyLebanon$110K
- Ida GitajnLebanon$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.